This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support the use of the PulseSelect Pulsed Field Ablation system for treatment of atrial fibrillation compared with thermal catheter ablation.
Publications
Hayes Publications are available through the Hayes Knowledge Center, a portal to world-class research and unbiased analyses on the clinical, financial, and risk impacts of emerging, controversial, and disruptive healthcare technologies.Every Hayes publication is developed by multidisciplinary teams of clinicians and scientists using rigorous methods grounded in internally recognized standards for systematic review and Health Technology Assessment. Learn more about these evidence resources and see sample titles below.
See below for some of our recent publications.
Hepzato Kit (Melphalan/Hepatic Delivery System; Delcath Systems Inc.) Liver-Directed Therapy for Metastatic Uveal Melanoma
The Melphalan/Hepatic Delivery System (Hepzato Kit; Delcath Systems Inc.) is a melphalan drug pack and catheter-based chemofiltration delivery kit indicated as a liver-directed treatment for adult patients with uveal melanoma with unresectable hepatic metastases affecting less than 50% of the liver and no extrahepatic disease, or extrahepatic disease limited to the bone, lymp…
V940 Individualized Neoantigen Therapy (Merck and Moderna) for Melanoma
V940 is an investigational messenger ribonucleic acid (mRNA)-based individualized melanoma vaccine.
ADAMTS13, Recombinant-krhn (Adzynma; Takeda Pharmaceutical Co. Ltd.) for Congenital Thrombotic Thrombocytopenic Purpura
ADAMTS13, recombinant-krhn (Adzynma; formerly TAK-755, BAX930, SHP655) (Takeda Pharmaceutical Co. Ltd.) is an intravenous human recombinant A disintegrin and metalloproteinase with thrombospondin motifs 13 (rADAMTS13) indicated for prophylactic or on demand enzyme replacement therapy in adult and pediatric patients with congenital thrombotic thrombocytopenic purpura.
TOPS System (Premia Spine) for Treatment of Symptomatic Lumbar Spondylolisthesis With Spinal Stenosis
This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support the use of the TOPS System (Premia Spine) for treatment of symptomatic lumbar spondylolisthesis with spinal stenosis.
AGENT Drug-Coated Balloon (Boston Scientific Corp.) for Coronary In-stent Restenosis
The AGENT Drug-Coated Balloon (Boston Scientific Corp.) is a paclitaxel-coated balloon catheter indicated for treatment of coronary in-stent restenosis (ISR). It is intended to be used after appropriate vessel preparation in adult patients undergoing percutaneous coronary intervention (PCI) in coronary arteries 2.0 millimeters (mm) to 4.0 mm in diameter and lesions up to 26 m…
RevitalVision Perceptual Learning Vision Training Program (Talshir Medical Technologies LTD) for Treatment of Amblyopia
This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support the use of RevitalVision for treatment of amblyopia in individuals aged 9 years or older.
dNerva Lung Denervation System (Nuvaira Inc.) for Chronic Obstructive Pulmonary Disease
The dNerva Lung Denervation System (Nuvaira Inc.) is an investigational, bronchoscopic catheter-based pulmonary nerve ablation system proposed to reduce the frequency and severity of chronic obstructive pulmonary disease (COPD) exacerbations.
Afamitresgene Autoleucel (Adaptimmune Therapeutics) for Advanced Synovial Sarcoma
Afamitresgene autoleucel is an investigational autologous engineered T-cell therapy for the treatment of HLA-A*02 positive patients with advanced synovial sarcoma expressing the MAGE-A4 antigen.
aXess Vascular Conduit (Xeltis) for Dialysis Access
The aXess graft (Xeltis) is a synthetic bioresorbable vascular conduit under investigation to establish arteriovenous access for hemodialysis in patients with end-stage renal disease.